Efficacy of an Ondansetron Orally Disintegrating Tablet: A Novel Oral Formulation of this 5-HT3 Receptor Antagonist in the Treatment of Fractionated Radiotherapy-Induced Nausea and Emesis

LeBourgeois, J.P. ; McKenna, C.J. ; Coster, B. ; Feyer, P. ; Franzén, L. ; Goedhals, L. ; Marzecki, Z. ; Souhami, L. ; Stewart, A. ; Tønnessen, F. ; Haigh, C. ; Mitchell, T. ; Wilkinson, J.R. ; Graham, E.

Clinical oncology (Royal College of Radiologists (Great Britain)), 1999-10, Vol.11 (5), p.340-347 [Periódico revisado por pares]

Amsterdam: Elsevier Ltd

Texto completo disponível